About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

LOGIN


Sign up to stay informed--receive email notifications for this journal

Journal of Adolescent and Young Adult Oncology

Editor-in-Chief: Leonard S. Sender, MD

ISSN: 2156-5333 • Published Quarterly • Online ISSN: 2156-535X

Current Volume: 3

Manuscript Submission

Journal of Adolescent and Young Adult Oncology (JAYAO) welcomes quantitative and qualitative clinical, basic science, and psychosocial manuscript submissions on all topics related to adolescent and young adult-aged cancer patients and survivors, including AYA-aged survivors of pediatric cancer.

JAYAO generally uses the National Cancer Institute's designated AYA age range of 15-39; however, it is acceptable for manuscripts submitted from institutions or countries typically using a younger lower age limit to use the lower age limit as appropriate. For a discussion about the age range included in adolescent and young adult oncology, please see the Controversies piece in JAYAO's inaugural issue (J Adolesc Young Adult Oncol. 2011;1(1):3-10).

 

Article Types

Note: All articles are peer-reviewed unless otherwise noted. Note the listed limits for text, figures/tables, and references below, but please be concise across all manuscript components. Those interested in an exception to a posted limit must contact the Editors prior to submission.

Original Articles present original quantitative or qualitative basic science, clinical, or psychosocial research

  • Abstract: Standard abstract 250 word limit. See standard abstract guidelines under Manuscript Components.
  • Text: 3,000 word limit.
  • Figures and Tables: Maximum of 8 total figures and/or tables.
  • References: Maximum of 100 references.

Review articles are systematic and critical reviews of the current literature on a topic

  • Abstract: Standard abstract 250 word limit, but structured headings not required.
  • Text: 4,500 word limit. Details on the study selection and inclusion process and on the participants in each selected study should be included.
  • Figures and Tables: Maximum of 10 total figures and/or tables.
  • References: Maximum of 250 references.

Case Study articles are unusual, illustrative, or instructive AYAO-relevant clinical cases

  • Abstract: Include a brief abstract of 100 words or less; structured headings are not required.
  • Text: 1,750 word limit. Include a concise literature review, brief overview of the case, and a brief summarizing conclusion. Be sure to discuss the relevance or importance of the case to AYAO.
  • Figures and Tables: Maximum of 3 total figures and/or tables.
  • References: Maximum of 25 references.

Brief Reports articles are short pieces about pilot studies, preliminary findings, very small sample sizes, or other research findings that are not suitable for a full Original Article

  • Abstract: Include a brief abstract of 100 words or less; structured headings are not required.
  • Text: 2,000 word limit. Include a concise literature review and a brief overview of the study, sufficient details on the study's methods and analysis, and a brief summarizing conclusion.
  • Figures and Tables: Maximum of 3 total figures and/or tables.
  • References: Maximum of 25 references.

Perspective articles are short pieces in which authors share or argue a viewpoint grounded in the literature but not linked to a specific article

  • Abstract: The final print version of accepted Perspective articles will not have an abstract. However, please include a maximum 100 word abstract with the submission to facilitate the review process.
  • Text: 1,500 word limit. The first paragraph should be a brief overview as there is no abstract. The perspective and points should be grounded in the literature. Include a brief summarizing conclusion.
  • Figures and Tables: Maximum of 3 total figures and/or tables.
  • References: Maximum of 25 references.

Letters to the Editor comment on recently published JAYAO articles

  • Special Notes: Letters to the Editor should be submitted within 6 weeks of the article's publication in print form. Include a short title related to but distinct from the recently published article. Provide the standard Title page, but no Running Head or Keywords. The Editors may choose to invite the authors to submit a response to the Letter. Not peer reviewed.
  • Abstract: The final print version of accepted Letters to the Editor will not have an abstract. However, please include a maximum 100 word abstract with the submission to facilitate processing.
  • Text: 500 word limit.
  • Figures and Tables: Maximum of 1 total figure and/or table.
  • References: No more than 5 references, one of which must be the JAYAO article being discussed.


Article Types that are Invite-Only or Require Pre-Submission Inquiry

Roundtable articles are transcribed discussions on a topic by leading members of the AYAO community

  • Invitation only, although those with a suggested topic are welcome to contact the Editors. Not peer reviewed.

Controversies articles include short responses by invited participants to hot topics in AYAO

  • Invitation only, although those with a suggested topic are welcome to contact the Editors. Not peer reviewed.

Clinical Trial Spotlight articles are brief summaries of clinical trials of importance or relevance to AYAO and still open to accrual

  • Invitation only, although those with a suggested topic are welcome to contact the Editors. Not peer reviewed.

Editorial pieces provide commentary and analysis of an article in the issue of JAYAO in which it appears

  • Invitation only. Not peer reviewed.

Book Reviews are 500-750 word pieces critically reviewing a book of AYAO-relevance

  • Invitation only, although those with a suggestion of a book to be reviewed are welcome to contact the Editors. Not peer reviewed.

Special Articles may include guidelines, meeting summaries, consensus statements, or other non-standard communications

  • Please contact the Editors prior to submission. May be subject to peer review.


Online Manuscript Submission

Manuscripts must be uploaded to Manuscript Central in a word processing format, preferably in Microsoft Word. Do not submit the manuscript or any of its components in PDF format. All authors on a submitted manuscript must have a Manuscript Central account.

Keywords and Abstract

Please note the keywords and abstract entered online in Manuscript Central are only to aid with the review process and are separate from the keywords and abstract on the title page for inclusion in the article.

Suggested Reviewers

Authors are encouraged to suggest the names and emails of appropriate reviewers, at least one of whom is not a member of JAYAO’s Editorial Board, during Manuscript Central submission, though final selection of reviewers is at the discretion of the Editors.

Cover Letter

Please include a cover letter from the corresponding author. The cover letter should include the following:

  • Running head character count (including spaces)
  • Abstract word count
  • Main text word count
  • Number of tables
  • Number of figures
  • Number of appendices (if applicable)
  • If the authors have published or submitted any related papers from the same study
  • If pre-submission permission was obtained to exceed the article type’s word limit
  • Authors are encouraged to detail the significance and uniqueness of the work


Manuscript Components

General Formatting and Style

  • Use of English Language: All submissions must be in English. JAYAO uses American-style English
  • Plagiarism: All submitted manuscripts will be processed through plagiarism detection software. Plagiarized manuscripts will be rejected
  • Word limits: See word limits under Article Types. Word limits do not include the Title Page, headings, Abstract, Acknowledgments, Disclaimer, Author Disclosure Statement, References, Figures, Tables, or legends. Permission to exceed an article type’s word limit must be given by the Editors prior to submission
  • Font: Times New Roman or Arial in 12-point type
  • Abbreviations: Expand all abbreviations at first mention in the text
  • Page size: Letter size (8.5 x 11 inches)
  • Margins: 1 inch
  • Line and word spacing: Double-space all lines; single-space all words
  • Page numbering: Number all pages in the lower-right corner. Do not include anything else in the header or footer

Title Page

The title (first) page of all manuscripts must contain the following information:

Exact title:

  • No proprietary names, trade names, or abbreviations

For each author:

  • Full name, including middle initial if applicable
  • Primary academic degrees (such as MD, DO, PhD, MPH, etc. No undergraduate or honorary degrees, fellowship or society memberships, etc.)
  • Institutional affiliation(s)
  • City, state, and country for each affiliation
  • Email address
  • Note:
    • - Group authors (i.e., “…on behalf of the XYZ Study”) are permissible
    • - Co-first authors are also permitted. On the title page, please put an asterisk after each co-first author and note them as such

Corresponding author:

  • Full name, including middle initial if applicable
  • Primary academic degrees (such as MD, DO, PhD, MPH, etc. No undergraduate or honorary degrees, fellowship or society memberships, etc.)
  • Institutional affiliation(s)
  • City, state, and country for each affiliation
  • Full mailing address
  • Phone number
  • Fax number
  • Email address

Running head:

  • 60 characters or fewer (including spaces, abbreviations acceptable)

Keywords:

  • Provide 4-6 keywords to be included in the article
  • Please do not use cancer, oncology, AYA, or adolescent and young adult as these are inherent in the journal itself

Abstract

A structured abstract using the following guidelines should accompany every manuscript unless otherwise noted above under Article Types. The abstract should appear on a separate page after the title page. The abstract should be no more than 250 words, formatted with the following headings:
              - Purpose
              - Methods
              - Results
              - Conclusion

  • Do not use proprietary or trade names
  • References are not permitted in the abstract
  • Headings do not contribute toward abstract word count

Acknowledgments

After the Conclusion of the main body of the manuscript, include a separate section acknowledging any contributors who did not meet the requirements for authorship and any science writers or corporate employees who participated in the development of the manuscript. Also include acknowledgments of research support for the study.

Disclaimer

After the Acknowledgments section, include a “Disclaimer” section, if needed, for the following:

  • Detail any important disclaimers (for example, the primary data collection organization for a secondary-analysis article)
  • Provide all appropriate details if any part of the manuscript was previously presented

Author Disclosure Statement

Following the Acknowledgments section (or Disclaimer if one was included), include a section entitled ‘‘Author Disclosure Statement.’’ Here authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals for further guidance. If no conflicts exist, the authors must state ‘‘No competing financial interests exist.’’

References

Authors are responsible for the accuracy and completeness of their references. Number references in the order they are cited in the text; do not alphabetize. In-text citations should be in numerical order, superscripted, not contained within parentheses or brackets, and placed after punctuation.

Reference section:

  • Check the Article Types section for reference number limits for some article types
  • Begin the Reference section on a separate page after the Author Disclosure Statement section
  • Double-space all lines and single-space between words
  • Articles accepted and in press are included in the Reference section
  • Personal communications, unpublished data, or manuscripts “in preparation” or “submitted for publication” should not be included in the Reference section. If necessary, these should be included at the appropriate place in the body of the text. Personal communications should include the contact’s first initial and last name, and the month and year of the communication
  • List all authors and/or editors up to 4; for 5 or more, list the first 3 followed by “et al.”
  • For books, volume and edition numbers should be included when appropriate
  • Abbreviate journal names in accordance with PubMed / MEDLINE   
  • No PMIDs or PCMIDs
  • References that are abstracts should be indicated as such, with the abstract number included, if applicable
  • Citation formats are based on NLM style, please see below for specific JAYAO format examples

Examples:

Journal article with 1-4 authors:

1.   Evan EE, Kaufman M, Cook AB, Zeltzer LK. Sexual health and self-esteem in adolescents and young adults with cancer. Cancer. 2006;107(7 Suppl):1672-9.

Journal article with 5 or more authors:

2.   Absolom K, Eiser C, Michel G, et al. Follow-up care for cancer survivors: views of the younger adult. Br J Cancer. 2009;101(4):561-7.

Abstract:

3.   Mullighan CG, Miller CB, Phillips LA, et al. IKZF1 (Ikaros) deletions are a hallmark of BCR-ABL1 positive acute lymphoblastic leukemia. Blood. 2007;110:abstract 721.

Book:

4.   Quinn GP, Vadaparampil ST (Eds). Reproductive health and cancer in adolescents and young adults. New York: Springer; 2012.

Chapter in a Book:

5.   Eiser C, Kuperberg A. Psychological support for adolescents and young adults. In: Bleyer WA, Barr RD (Eds). Cancer in adolescents and young adults. New York: Springer; 2007; pp. 365-74.

Report:

6.   Adolescent and Young Adult Oncology Progress Review Group. Closing the gap: research and cancer care imperatives for adolescents and young adults with cancer (NIH Publication No. 06-6067). Bethesda, MD: Department of Health and Human Services, National Institutes of Health, National Cancer Institute, and the LIVESTRONG Young Adult Alliance; August 2006. Accessed February 7, 2011 from: http://planning.cancer.gov/library/AYAO_PRG_Report_2006_FINAL.pdf

Tables

Within the text, cite tables in the order in which they appear using Arabic numerals. Tables in accepted articles will be typeset and placed near the first mention of the table in the text; do not include separate lines indicating table placement.

Table guidelines:

  • Check the Article Types section for limits on the number of tables and/or figures for some article types
  • Either prepare all tables on separate pages in the main document following the References section OR submit each table as a separate word processing document. Do not embed tables within the main body text
  • Provide a brief but descriptive title for each table. Avoid abbreviations in the table title when possible
  • Table footnote(s) should include any essential notes and must include definitions of all abbreviations and acronyms used in the table

Figures

Within the text, cite figures in the order in which they appear using Arabic numerals. Figures in accepted articles will be typeset and placed near the first mention of the figure in the text; do not include separate lines indicating figure placement.

Figure guidelines:

  • Check the Article Types section for limits on the number of tables and/or figures for some article types
  • Figures include graphs, charts, diagrams, illustrations, and photographic images
  • File types and guidelines:
    - All figures must be submitted as separate picture files. Do not embed figures in the main word processing document
    - Do not submit figures as PDFs, PowerPoint, or Excel files
    - To ensure proper print quality, please submit only TIFF or EPS files. JPEG files are for screen representation-quality only and will print very poorly during the printing process
    - Line illustrations should be submitted at 900 DPI.  Halftones and color should be submitted at a minimum of 300 DPI
  • Color figures:
    - Color art must be saved as CYMK, not RGB. (Note: If RGB files are submitted, the files will be converted to CYMK and some color variation will occur)
  • Figure legends:
    - After the Reference section of the main word processing document (or any Tables included in the word processing document), include a separate page with the following information for each figure:
    - Provide a brief but descriptive title for each figure. Avoid abbreviations in the figure title when possible
    - Define all relevant information in figures, including figure part labels, footnotes, abbreviations, acronyms, arrows, and levels of magnification in insets

 

Online-Only Materials

Appendices and other supplementary materials should be included only when they are pertinent to the submitted manuscript but beyond the word or table/figure limits.

Appendix and supplementary material guidelines:

  • Published only with the online version of an accepted article
  • The print version of the article will include a URL directing readers to the online-only materials
  • Should be important to understanding or interpretation of the manuscript and limited in length
  • Should be original and not previously published
  • Acceptance of online-only materials is separate from acceptance of the manuscript and at the Editors’ discretion
  • Authors are encouraged to contact the Editors prior to submission of online-only materials

 

Helpful Hints

  • Clarification of ‘AYA’: Abstracts and the beginning of manuscripts should clearly distinguish whether ‘AYA-aged patients,’ ‘AYA-aged survivors (of AYA cancer),’or ‘AYA-aged survivors (of pediatric cancer)’ are being discussed
  • Variations of ‘AYA’: Authors should use the terminology most appropriate to their manuscript’s age range and country or institution. While ‘adolescent and young adult (AYA)’ is most commonly used in JAYAO, ‘teenage and young adult (TYA),’ ‘young adult (YA),’ adolescent, and other such variations may be used as appropriate
  • Description of age: All manuscripts must clearly state the age range included in both the abstract and main body. Manuscripts discussing survivors must include information about participants’ age both at diagnosis and at study
  • Background and introduction of AYAO in manuscripts: As JAYAO is an entirely AYA-focused journal, please be mindful that the background or introduction section of a manuscript submitted to JAYAO may not need to be as long nor as detailed as an AYAO-focused manuscript submitted to another journal
  • Pre-submission inquiry for manuscripts exceeding word limits: Permission to exceed an article type’s word limit must be given by the Editors prior to submission
  • Revision word limits: Article type word limits apply to revisions as well as initial submissions
  • Pre-submission inquiry for manuscripts with online-only appendices: Authors are encouraged to contact the Editors prior to submission of online-only materials
  • Duplicate author/reviewer accounts in Manuscript Central: Please do not create a duplicate author account when entering authors for a newly-submitted manuscript. If details of an account need to be altered, please contact the Editors
  • Questions and inquiries: Please direct all questions and inquiries to the Editors

 

Post-Submission Information

Submission-Related Emails and Online Status

The Manuscript Central system sends emails only to the corresponding author (except for copyright release emails for accepted articles). Submitted manuscripts will show in the Manuscript Central Author Center of only the corresponding author.

Manuscript Decisions

Manuscripts may receive decisions of Reject, Major Revision, Minor Revision, Accept with Edits, or Accept. A manuscript decision of Major Revision or Minor Revision does not guarantee the manuscript will ultimately be accepted. Article type word limits apply to revisions as well as initial submissions. A manuscript with a decision of Accept with Edits will not receive a formal Accept decision until all requested edits are satisfactorily completed.

Post-Acceptance Information

Permissions

Authors are responsible for procuring permissions to reproduce illustrations or tables taken from other publications and must be acknowledged by a complete credit line in the figure legend. The original publisher’s letter of permission should be available for submission to Journal of Adolescent and Young Adult Oncology if requested by the Editors or the Publisher. A full citation should also be included in the Reference section.

Page Proofs

An email containing a link to the PDF file of the page proof is sent to the corresponding author. The proof should be read carefully and returned within 3 business days to the Publisher with the author’s/authors’ approval or corrections.

Reprints

Reprints may be ordered by following the special instructions that accompany page proofs and should be ordered at the time the corresponding author returns the corrected page proofs. Reprints ordered after an issue is printed will be charged at a substantially higher rate.

Publisher

Journal of Adolescent and Young Adult Oncology is published quarterly by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215, Tel: (914) 740-2100; Fax: (914) 740-2101; Email: info@liebertpub.com;  Website: www.liebertpub.com/JAYAO

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Journal of Palliative Medicine

    Journal of Palliative Medicine

    The leading interdisciplinary journal reporting on the clinical, educational, legal, and ethical aspects of palliative care for patients in end of life or with intractable pain, focusing on improving quality of life.

    Cancer Biotherapy and Radiopharmaceuticals

    Cancer Biotherapy and Radiopharmaceuticals

    The established journal with over 25 years of peer-reviewed papers on new and innovative investigations of methods to improve cancer therapy. The Journal focuses on advancements in radioimmunotherapy and radiopharmaceuticals.

    Monoclonal Antibodies
    in Immunodiagnosis
    and Immunotherapy

    Monoclonal Antibodies
    in Immunodiagnosis
    and Immunotherapy

    formerly Hybridoma

    The essential journal for scientists and clinicians in the fields of molecular immunology and immunopathology, and for all those applying molecular immunological methods for experimental and therapeutic purposes.

    Journal of Interferon
    & Cytokine Research

    Journal of Interferon
    & Cytokine Research

    Presents the latest findings and reviews of research covering IFNs and cytokines, their relevance to chronic and acute disease, studies involving cytokine biology, mechanisms of IFN action, and their role in virus infection.

Browse All Publications »